Are we hitting the right combination for hormonally sensitive breast cancer?
Tripathy
Debu
D
D000818:Animals; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D014408:Biomarkers, Tumor / Q000378:metabolism*; D001943:Breast Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000378:metabolism; D019008:Drug Resistance, Neoplasm; D005260:Female; D006801:Humans; D009376:Neoplasms, Hormone-Dependent / Q000737:chemistry / Q000000981:diagnostic imaging / Q000188:drug therapy*; D018579:Patient Selection; D049268:Positron-Emission Tomography; D015398:Signal Transduction / Q000187:drug effects; D016896:Treatment Outcome
D014408:Biomarkers, Tumor